版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
COVID-19
InfectionPreventionandControl
Livingguideline
Maskuseincommunitysettings
22December2021
WorldHealth
•Organization
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
2of38
Sections
1.
ExecutiveSummary 3
1.1
Abbreviations 3
1.2
Definitions 4
2.
Methodology 5
3.
Advice,statementsandrecommendations 7
3.1
Generalmaskadvice 7
3.2
Maskuseincommunitysettings 7
3.2.1
Maskuseduringphysicalactivity 15
3.2.2
Typeofmaskusedbythegeneralpublic 16
3.3
Maskusebychildren 22
4.
Acknowledgements 29
References 31
WHOcontinuestomonitorthesituationcloselyforanychangesthatmayaffectthislivingguideline.Shouldanyfactorschange,WHOwillissueafurtherupdate.Otherwise,thislivingguidelinewillexpire2yearsafterthedateofpublication.
©WorldHealthOrganization2021.Somerightsreserved.Thisworkisavailableunderthe
CCBY-NC-SA3.0IGOlicence
.WHOreferencenumber:WHO/2019-nCoV/IPC_masks/2021.1
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
3of38
1.ExecutiveSummary
InfoBox
Version1.0InfectionPreventionandControlinthecontextofcoronavirusdisease(COVID-19):LivingGuideline
ThisfirsteditionoftheInfectionPreventionandControlinthecontextofcoronavirusdisease(COVID-19):LivingGuidelineprovidesthemostuptodatetechnicalguidanceonmaskuseincommunitysettingsinthecontextofCOVID-19.ThislivingguidelineincorporatestheGradingofRecommendations,Assessment,DevelopmentandEvaluations(GRADE)processes(seeMethodologysection)withexisting(previouslypublished)technicalguidanceinMAGICapptoallowuserstoeasilynavigateinfectionpreventionandcontrol(IPC)guidelinesinthedynamicsituationofCOVID-19.Thiseditiontakesintoconsiderationtheevolvingepidemiologicalsituation,includingtheemergenceoftheVoCOmicron.FurtherinformationonOmicronVoCcanbefoundinthefollowingtechnicaldocumentEnhancingReadinessforOmicron(B.1.1.529):TechnicalBriefandPriorityActionsfortheMemberStates,issuedbyWHOon17December2021[1].
Thisdocumentisalivingguideline,whereupdatedornewstatementswillbeaddedasnewevidenceemergesthatwillbereviewedthroughtheGRADEprocess.Thus,theguidelineiswritten,disseminated,andupdatedinMAGICapp.Itsuser-friendlyformatandstructureallowforeasynavigationwhileaccommodatingforthedynamicnatureoftheCOVID-19publichealthemergencyandassociatedevidenceandrecommendations.MAGICAppallowshighlightingofnewandupdatedstatementswhilekeepingexistingstatementsandsupportingevidencewithintheguideline.Thestatementsaremarkedwithdifferentlabelsandcolourcodingtoreflectthedifferentconsolidationapproachesofexistingguidance,updates,andnewstatements.
Inthisedition,newinformationincludesupdatedmaskrecommendationsforthegeneralpublic,astatementonpoliciesforappropriateadherencetoacomprehensivepackageofpreventivemeasurestoreducesevereacuterespiratorysyndromecoronavirus2(SARS-CoV-2)transmission,astatementonthetypeofmasktobeusedbyhigher-riskindividuals,andimplementationconsiderationsforthetypeandminimumessentialparametersofmasksusedincommunitysettings.
ThepreviouslypublishedtechnicalguidancedocumentsincorporatedinVersion1.0areasfollows:
1.
MaskuseinthecontextofCOVID-19-December2020
;and
2.
AdviceontheuseofmasksforchildreninthecontextofCOVID-19
-August2020;.
TheWorldHealthOrganization(WHO)recommendstheuseofmasksaspartofacomprehensivepackageofpreventionandcontrolmeasurestolimitthespreadofSARS-CoV-2,thevirusthatcausesCOVID-19.Evenwhenusedcorrectly,amaskaloneisinsufficienttoprovideadequateprotectionorsourcecontrol.Otherpublichealthandsocialmeasuresincludetesting,isolation,contacttracing,quarantine,adequateventilationinindoorsettings,aphysicaldistancingofatleast1metre,handhygiene,andrespiratoryetiquette.Together,thesemeasuresarecriticaltopreventhuman-to-humantransmissionofSARS-CoV-2.Thisdocumentguidesdecision-makers,publichealthandIPCprofessionals,childhealthprofessionalsandnon-medicalmaskmanufacturers.
1.1Abbreviations
aOR
adjustedoddsratio
COVID-19
coronavirusdisease2019
CI
ConfidenceInterval
EtD
EvidencetoDecision
GDG
GuidelineDevelopmentGroup
GRADE
GradingofRecommendations,Assessment,DevelopmentandEvaluations
ILI
Influenza-likeillness
IPA
InternationalPaediatricAssociation
IPC
infectionpreventionandcontrol
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
4of38
NIOSH
NationalInstituteforOccupationalSafetyandHealth
OR
oddsratio
PPE
personalprotectiveequipment
SARS-CoV
severeacuterespiratorysyndromecoronavirus
SARS-CoV-2
severeacuterespiratorysyndromecoronavirus2
UNICEF
UnitedNationsChildren'sFund
UK
UnitedKingdom
USA
UnitedStatesofAmerica
WHO
WorldHealthOrganization
VoC
VariantofConcern
1.2Definitions
Definitions
Healthworkersareallpeopleprimarilyengagedinactionswiththeprimaryintentofenhancinghealth.Examplesarenursingandmidwiferyprofessionals,doctors,cleaners,otherstaffwhoworkinhealthfacilities,socialworkersandcommunityhealthworkers.
Medicalmasksaredefinedassurgicalorproceduremasksthatareflatorpleated,andtheyareaffixedtotheheadwithstrapsaroundtheears,head,orboth.Theirperformancecharacteristicsaretestedaccordingtoasetofstandardizedtestmethods(ASTMF2100,EN14683,orequivalent)thataimtobalancehighfiltration,adequatebreathabilityand,optionally,fluidpenetrationresistance[5][121].
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
5of38
2.Methodology
Methodologyfordevelopingthestatements
StatementsincludedinthisdocumentarebasedonpublishedWHOguidelines(inparticular,theWHOGuidelinesoninfectionpreventionandcontrolofepidemic-andpandemic-proneacuterespiratoryinfectionsinhealthcare)andongoingevaluationsofallavailablescientificevidencebyWHOCOVID-19IPCGuidanceDevelopmentGroup(GDG)(seeAcknowledgements).Thisevidenceisevaluatedthroughexpeditedsystematicreviewsandexpertconsensus-buildingthroughregularGDGconsultationsfacilitatedbyamethodologist.Whenfurtherclarityorconsensusisnecessary,meetingsarefollowedupbyavotingprocessbytheGDGmembers.Recommendationsarebasedonanassessmentofthebalanceofbenefitstoharmsaswellascertaintyintheseassessments.Thisprocessalsoconsiders,asmuchaspossible,potentialresourceimplications,valuesandpreferences,feasibility,equityandethics.Anexternalreviewpanelofexpertsreviewsdraftguidancedocumentsbeforepublication.
Methodologyfordevelopingthislivingguideline
Asdescribedintheexecutivesummary,giventhedynamicsituationoftheCOVID-19pandemic,thisfirsteditionofthislivingguidelinecombinesexistingguidanceformulatedthroughexpertreviewofevidence,theGRADEevidence-to-decision(EtD)framework,andstandardsfortrustworthyguidelines.ForrecommendationsfollowingtheGRADEEtDframework,aGDGcomprisedofindividualswithbroadexpertisespanningmultiplespecialtiesacrossallWHOregions(seeAcknowledgements)wasconvenedovermultiplemeetingswhereGDGmembersreachedagreement(throughconsensusorvotewithsupermajority)onthestatements.
ManagingConflictsofInterest
AfteranalyzingtheDeclarationofInterestformsandconductingtherequiredinternetsearch,WHOconcludednomemberhadfinancialorcommercialinterestsrelatedtoCOVID-19andmasks.Methodsarealignedwith
WHOHandbookforguidelinedevelopment
.
Readershipcuesforapproachesusedtodevelopstatements
Giventheconsolidationprocess,thestatementsaremarkedwithdifferentlabelsandcolourcodestoreflectthesetwoapproaches.ThegreencheckmarksreflectstatementsthatweredevelopedusingtheGRADEEtDframework.PurplecheckmarksrefertostatementsthathavenotgonethroughtheGRADEEtDframeworkprocessbutareinformedbyevidencereviewandaretheproductofexpertconsensus.Thegreybarreferstoimplementationconsiderationswhichsupportstatementsthroughpracticaladvice,andaretheproductofexpert
consensus.
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
6of38
GRADEEtDFramework
GRADEratesscientificevidencetodevelopevidence-basedguidelines.Eachrecommendationisassignedastrengthofrecommendationandqualityofevidence.
GRADEevidenceprofilescontainanassessmentofthequalityoftheevidenceandasummaryoffindingsforeachcriticaloutcomeandeachkeyquestion.TheGDGusesthesesummariesasthebasisfordiscussionsandformulationofrecommendations.
Goodpracticestatementsandimplementationconsiderations
Goodpracticestatementsindicateactionsthatshouldbeimplemented,inmostcircumstances,whenthecertaintysurroundingtheeffectestimatesishigh,butthesupportiveevidenceisindirect.Benefitsarebasedonmultiplebodiesofindirectevidence,oftenchallengingtoreviewsystematically.Goodpracticestatementsaregenerallyreservedforconsiderationswithwidespreadconsensusandwhentheinterventioniswidelyaccepted.Implementationconsiderationsarecriticalelementsthatfacilitatetheappropriateuseofformalstatements.
Timeline
AnexternallivingsystematicreviewhasbeencommissionedtocontinuouslymonitoremergingevidenceontheuseofmasksinthecontextoftheCOVID-19publichealthemergencyofinternationalconcern.Theemergingevidencewilltriggercontinuousupdatesastheneedisidentified.
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
7of38
3.Advice,statementsandrecommendations
3.1Generalmaskadvice
InfoBox
Maskmanagement
Foranytypeofmask,appropriateuse,storage,cleaningordisposalareessentialtoensurethattheyareaseffectiveaspossibleandtoavoidanyincreasedriskoftransmission.Adherencetocorrectmaskmanagementpracticesvaries,reinforcingtheneedforappropriatemessaging[115].WHOprovidesthefollowingguidanceonthecorrectuseofmasks:
•Washhandsthoroughlybeforeputtingonthemask.
•Inspectthemaskfortearsorholes,anddonotuseadamagedmask.
•Placethemaskcarefully,ensuringitcoversthemouthandnose,adjusttothenosebridgeandtieitsecurelytominimizeanygapsbetweenthefaceandthemask.Ifusingearloops,ensurethesedonotcrossoverasthiswidensthegapbetweenthefaceandthemask.
•Avoidtouchingthemaskwhilewearingit.Ifthemaskisaccidentlytouched,washhandsthoroughly.
•Removethemaskusingtheappropriatetechnique.Donottouchthefrontofthemask;rather,untieitfrombehind.
•Replacethemaskassoonasitbecomesdampwithanew,cleananddrymask.
•Eitherdiscardthemaskorplaceitinacleanplasticresealablebagwhereitiskeptuntilitcanbewashedandcleaned.Donotstorethemaskaroundthearmorwristorpullitdowntorestaroundthechinorneck.
•Washhandsimmediatelyafterdiscardingamask.
•Donotreusesingle-usemasks.
•Discardsingle-usemasksaftereachuseandproperlydisposeofthemimmediatelyuponremoval.
•Donotremovethemasktospeak.
•Donotshareyourmaskwithothers.
•Washfabricmasksinsoapordetergentandpreferablyhotwater(atleast60°Centigrade/140°Fahrenheit)atleastonceaday.Ifitisnotpossibletowashthemasksinhotwater,thenwashthemaskinsoap/detergentandroom-temperaturewater,followedbyboilingthemaskfor1minute.
•Amaskshouldbechangedtoacleanmaskatleastoncedaily.
Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.
Exhalationvalvesonrespiratorsandnon-medicalmasksarediscouragedastheydonotallowforadequatesourcecontrolfromthewearer.Exhalationvalvespermitbypassofthefiltrationlayerswhenthewearerexhales,potentiallyallowingpass-throughofinfectiousparticles.
Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.
3.2Maskuseincommunitysettings
8of38
InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2
Updated
Strongrecommendationfor,Moderatecertaintyevidence
InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2,irrespectiveofvaccinationstatusorhistoryofpriorinfection,wearingawell-fittingmask*thatcoversthenoseandmouthisrecommendedforthegeneralpublicwheninteractingwithindividualswhoarenotmembersoftheirhousehold:
•inindoorsettingswhereventilationisknowntobepoororcannotbeassessed,ortheventilationsystemisnotproperlymaintained,regardlessofwhetherphysicaldistancingofatleast1metrecanbemaintained1;
•inindoorsettingsthathaveadequateventilationifphysicaldistancingofatleast1metrecannotbemaintained*;or
•inoutdoorsettingswherephysicaldistancingofatleast1metrecannotbemaintained*.
*Masktypesinclude:
•reusable,non-medicalmasksthatcomplywiththe
ASTMF3502
standardor
CENWorkingAgreement17553
,oranon-medicalmaskmeetingWHOessentialparameters(seepracticalinfoformoreinformation).;
•disposablemedicalmasks,complyingwithmedicalmaskstandardsEN14683TypeI,ASTMF2100Level1,YY/T0969,YY0469(orequivalent)iftheavailabilityofmedicalmasksmeetingminimumperformancecriteriaforhealthworkershasbeenassured**;
•iftheaboveoptionsarenotavailable,othertypesofwell-fittingnon-medicalmasksincludinghomemademultilayeredmasks***areanacceptableoption(accordingtolocalpolicies).
1Physicaldistanceshouldbeincreasedbeyond1metrewheneverfeasible.
Updated22December2021.
PracticalInfo
Forinformationonassessingandimprovingindoorventilation,pleaseseeWHO's
Roveensureg
oadmaptoimprandoodindoor
venconoCOVID-19
tilationinthetextf.
Practicalconsiderationsforpolicy-makers:
Thepotentialadvantagesofmaskusebyhealthypeopleinthegeneralpublicinclude:
•reducedspreadofpotentiallyinfectiousaerosolsordropletsfromexhaledbreath,includingfrominfectedpeoplebeforetheydevelopsymptoms[15];
•encouragingconcurrenttransmissionpreventionbehaviourssuchaswashinghandsandnottouchingtheeyes,noseandmouth[16][17][18];and
•preventingtransmissionofotherrespiratoryillnessessuchastuberculosisandinfluenzaandreducingtheburdenofthesediseasesduringthepandemic[19].
Thepotentialdisadvantagesofmaskusebyhealthypeopleinthegeneralpublicinclude:
•headacheand/orbreathingdifficulties,dependingonthetypeofmaskused[12];
•developmentoffacialskinlesions,irritantdermatitisorworseningacnewhenusedfrequentlyforlonghours[13][20];
•difficultywithcommunicatingclearly,especiallyforpersonswhoaredeaforhavepoorhearingoruselipreading[21][22];
•poorcompliancewithmask-wearing,inparticularbyyoungchildren[24][25][26][27];
•wastemanagementissues;impropermaskdisposalleadingtoincreasedlitterinpublicplacesandenvironmentalhazards[28];and
•furtherdisadvantagesfor,ordifficultywearingmasksby,certainmembersofthepopulation,especially:children;
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
9of38
developmentallychallengedpeople;thosewithmentalillnessorcognitiveimpairment;thosewithasthma,chronicrespiratoryorbreathingproblems;thosewhohavehadfacialtraumaorrecentoralmaxillofacialsurgery;andthoselivinginhotandhumidenvironments[12][25].
EvidenceToDecision
Benefitsandharms
Substantialnetbenefitsoftherecommendedalternative
TheutilizationofmasksincommunitysettingsislikelyassociatedwithadecreasedriskofSARS-CoV-2infectionscomparedwithnomask-wearing.SARS-CoV-2B.1.617.2(Delta)varianthasbeenreportedtohaveincreased
transmissibility[29][30][31][33][32];mostGDGmembers,therefore,agreedthat,inthecontextoftheDeltavariant,thebenefitsofmask-wearinginthecommunitysettingoutweighpotentialharms.EcologicalstudieshaveidentifiedanassociationwithdecreasednumberofconfirmedcasesofCOVID-19andpoliciesrequiringtheuseofmasks[34][35][36].Aclusterrandomizedcontrolledtrialevaluatingmaskpromotion(asanindirectpublichealthintervention)foundthatinacountrywithlowmaskuse,maskpromotionincreasedmaskuseanddecreasedsymptomaticSARS-CoV-2seroprevalence[37].Conversely,anotherrandomizedcontrolledtrialfoundnostatisticalsignificanceassociatedwithsurgicalmaskuseandareducedriskofSARS-CoV-2[38].Thestudyprovidedanimpreciseestimateformaskutilizationversenoutilization;however,thestudywasnotdesignedtoevaluatetheeffectivenessofmaskuseforsourcecontrol.
ManyGDGmembersnotethat,eventhoughthecertaintyoftheevidenceismoderate,thereisasubstantialneedforWHOtoproducecohesiveandrobustrecommendations,asthenetbenefitsofmaskusebythegeneralpublicoutweighthepotentialharms.
Moderate
CertaintyoftheEvidence
Balanceofdesirableandundesirableoutcomes.
Preferenceandvalues
Nosubstantialvariabilityexpected
DiscussionswithstakeholdersandIPCGDGmembershaveindicatedageneralpreferencetofavourmaskuseincommunitysettings.ManyGDGmembersnotethat,inthecontextoftheDeltavariantandothervariantsofconcern,maskingisavitalSARS-CoV-2mitigationmeasure.Membersexpressedaneedtodocumentaclearopinionontheuseofmasksincommunitysettings,giventheimpactoflocalandnationalvaluesandpreferencesonIPCpolicies.Giventheavailabilityofmasks,communitymaskingislikelyfeasible.
Resourcesandotherconsiderations
Noimportantissueswiththerecommendedalternative
ManyGDGmembersnotedtheglobalsupplychainformaskmanufacturinghasimprovedandwouldnotposeasevereobstacletocommunitymasking.Thecostofbothmedicalmasksandnon-medical(fabric)masksarerelativelylow,anddonotposeasubstantialbarrierforlow-andmiddle-incomecountries.
Gapsinknowledgeandresearchneeds
Investigationsontheutilizationofmasksinthecommunitysettingareongoing;however,publishedworkhasidentifiedtheneedforcontinuedresearch.Wellconductedobservationalstudiesand/orrandomizedcontrolledtrialsexploringtheuseofmasksversusnomasksinvarioussettings(e.g.indoor,outdoor,ventilationstatus,etc.)wouldfurtherclarifyoutstandinginquiriesconcerningmaskuseincommunitysettings.Inaddition,researchinvestigatingtheuseofmasks(includingtypeofmaskandtransmissionscenarios)inthecontextoftheDeltavariantwouldprovidepowerfulevidenceforfuturerecommendations.However,GDGmembersdiscussedthechallengesassociatedwithobtainingcompellingevidencefromarandomizedcontrolledtrialonbehaviouralinterventions.Furthermore,withtheavailabilityofaSARS-CoV-2inoculation,furtherresearchwillbeneededtoreinforcetheimpactofvaccinationonmaskutilizationincommunitysettings.
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
10of38
Justification
GDGmemberswereaskedtoevaluatethestrengthoftheproposedrecommendation(strongrecommendationversusconditionalrecommendation).Basedontheavailableevidence,theGRADEprocessandtheEvidencetoDecisionframework,theIPCGDGagreedonastrongrecommendation.TheopinionoftheGDGwassolidifiedviaanonlinesurvey,inwhich82.1%(23/28)ofGDGmembersvotedforastrongrecommendationand17.9%(5/28)votedforaconditionalrecommendation.
New
Goodpracticestatement
InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2,policiesshouldbedeveloped,strengthenedandimplementedtoencourageappropriateadherencetoacomprehensivepackageofpreventivemeasurestoreducetransmission(ventilation,physicaldistance,handhygiene,andrespiratoryetiquette)includinginparticular,maskadherencebythegeneralpublic.
Updated22December2021.
Justification
GDGmemberswereinitiallyaskedifWHOshoulddevelopastatementontheimportanceofmask-wearingand/orinterventionstoimproveadherencetomask-wearingguidance;however,manymembersthoughtitwasessentialtoconsiderthe“bundle”ofpublichealthsocialmeasuresthatpertaintothegeneralpublic.Theabovegoodpracticestatementwasdeterminedbyanonlinevote,where27GDGmembersresponded,with55.6%(15)votingforthestatementasmentionedabove,whiletheremaining44.4%(12)votedforslightlydifferentwordingforthegoodpracticestatement.
InalltransmissionscenariosofSARS-CoV-2
InfoBox
Updated
Implementationconsideration
Inareaswithknownorsuspectedsporadictransmission,ornodocumentedtransmission,WHOadvisethatdecision-makersshouldapplyarisk-basedapproachfocusingonthefollowingcriteriawhenconsideringtheuseofmasksforthegeneralpublic:
•purposeofmaskuse;
•riskofexposuretoSARS-CoV-2;
•vulnerabilityofthemaskwearer/population;
•settinginwhichthepopulationlives;
•feasibility;
•typeofmask;
•vaccinationcoverage;and
•circulatingvariantsofconcern.
Updated22December2021.
Justification
GDGmembersnotedtheimportanceofincludingvaccinationcoverageandcirculatingvariantsofconcerntotheimplementation
11of38
considerationsgiventheavailabilityofvaccinationandthecurrentlandscapeofSARS-CoV-2transmission.
Inanytransmissionscenario,personswithanysymptomssuggestiveofCOVID-19shouldwearamedicalmaskandadditionally:
•self-isolateandseekmedicaladviceassoonastheystarttofeelunwellwithpotentialsymptomsofCOVID-19(evenifsymptomsaremild);
•followinstructionsonhowtoputon,takeoffanddisposeofmedicalmasksandwashhandsthoroughly[39];
•followalladditionalmeasures,inparticular,respiratoryhygiene,frequenthandwashingandmaintainingaphysicaldistanceofatleast1metrefromotherpersons[75].
•IfamedicalmaskisnotavailableforindividualswithsuspectedorconfirmedCOVID-19,afabricmaskwithfit,filtrationandbreathabilityassessedtomeetWHO'sessentialparametersfornon-medicalmasksshouldbewornbypatientsasasourcecontrolmeasure,pendingaccesstoamedicalmask.Theuseofanon-medicalmaskcanminimizetheprojectionofrespiratoryparticlesfromtheuser[40][41]
AsymptomaticpersonswhotestpositiveforSARS-CoV-2shouldwearamedicalmaskwhenwithothersforaperiodof10daysaftertestingpositive.
Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.
EvidenceToDecision
CertaintyoftheEvidence
Evidenceontheprotectiveeffectofmaskuseincommunitysettings
Atpresent,thereisonlylimitedandinconsistentscientificevidencetosupporttheeffectivenessofmaskinghealthypeopleinthecommunitytopreventinfectionwithrespiratoryviruses,includingSARS-CoV-2[6].Alargerandomizedcommunity-basedtrialinwhich4862healthyparticipantsweredividedintoagroupwearingmedical/surgicalmasksandacontrolgroupfoundnodifferenceininfectionwithSARS-CoV-2[42].Arecentsystematicreviewfoundninetrials(ofwhicheightwerecluster-randomizedcontrolledtrialsinwhichclustersofpeople,versusindividuals,wererandomized)comparingmedical/surgicalmasksversusnomaskstopreventthespreadofviralrespiratoryillness.Twotrialsinvolvedhealthcareworkersandsevenhadcommunity-basedparticipants.ThereviewconcludedthatwearingamaskmaymakelittleornodifferencetothepreventionofILI(RR:0.99;95%CI:0.82–1.18)orlaboratory-confirmedinfluenza(LCI)(RR:0.91;95%CI:0.66–1.26)[11];thecertaintyoftheevidencewaslowforILI,moderateforLCI.
Bycontrast,asmallretrospectivecohortstudyfromBeijingfoundthatmaskusebyentirefamiliesbeforethefirstfamilymemberdevelopedCOVID-19symptomswas79%effectiveinreducingtransmission(oddsratio(OR):0.21;CI0.06-0.79)[43].Acase-controlstudyfromThailandfoundthatwearingamedicalornon-medicalmaskallthetimeduringcontactwithaCOVID-19patientwasassociatedwitha77%lowerriskofinfection(adjustedoddsratio(aOR)0.23;95%CI0.09–0.60)[44].SeveralsmallobservationalstudieswithepidemiologicaldatahavereportedanassociationbetweenmaskusebyaninfectedpersonandthepreventionofonwardstransmissionofSARS-CoV-2infectioninpublicsettings[2][45][46][47].
Anumberofstudies,somepeer-reviewedbutmostpublishedaspre-prints,reportedadeclineinthenumberofCOVID-19casesassociatedwithfacemaskusebythepublic,usingcountry-orregion-level
data.[48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69].Onestudyreportedanassociationbetweencommunitymask-wearingpolicyadoptionandincreasedmovement(lesstimeathome,increasedvisitstocommercial
12of38
locations)[23].Thesestudiesdifferedinsetting,datasourcesandstatisticalmethods,andhaveimportantlimitationstoconsider[70],notablythelackofinformationaboutactualexposureriskamongindividuals,adherencetomask-wearingandtheenforcementofotherpreventivemeasures[71][72].
Studiesofinfluenza,ILIandhumancor
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 二零二四年度汽车制造车间装修合同
- 汽车赠予合同范本
- 玻璃报价合同范本
- 二零二四年度商标许可使用合同标的及许可条件具体描述
- 2024年度房屋买卖合同:详细描述房屋基本信息、买卖价格及付款方式
- 2024年度广告发布合同的媒体选择与费用分配
- 2024年度个性化盘扣购销合同
- 二零二四年度联合研发合同研发项目与分工合作
- 2024专利申请权的转让合同
- 防水单位合同范本
- 语文课前三分钟演讲西塘古镇课件
- qq仪表dcs-io表热水循环泵出口压力
- 病理产科 死胎 (妇产科学课件)
- 翻身拍背课件
- 全套课件-中文版AutoCAD-2020基础教程-完整
- 2022最新 冰壶教案
- 中医穴位养生保健课件
- 属地管理课件
- 可行性研究报告编制工作流程
- 国家开放大学《可编程控制器应用实训》形考任务2(实训二)参考答案
- 木薯淀粉预处理及其糖化工艺初步设计
评论
0/150
提交评论